APO Research
Talk to an analyst

APO RESEARCH · REPORT

TB Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global TB Vaccines Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchTB Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal TB Vaccines Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal TB Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TB Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal TB Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global TB Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for TB Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for TB Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for TB Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for TB Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of TB Vaccines include China National Biotec Group, Sanofi Pasteur, Merck & Co.,Inc, Statens Serum Institut, Serum Institute, Japan BCG Laboratory, InterVax Ltd, India Pvt. Ltd and GreenSignal, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for TB Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of TB Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for TB Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TB Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global TB Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for TB Vaccines sales, projected growth trends, production technology, application and end-user industry.

TB Vaccines Segment by Company

China National Biotec Group

Sanofi Pasteur

Merck & Co.,Inc

Statens Serum Institut

Serum Institute

Japan BCG Laboratory

InterVax Ltd

India Pvt. Ltd

GreenSignal

Bio Pharma Limited

TB Vaccines Segment by Type

Immunotherapeutic Vaccines

Booster Vaccines

Others

TB Vaccines Segment by Application

Private Clinics

Research Institutes

Hospitals

TB Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TB Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TB Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TB Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of TB Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TB Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global TB Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immunotherapeutic Vaccines Major Manufacturers Table 3. Booster Vaccines Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global TB Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Private Clinics Major Manufacturers Table 7. Research Institutes Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. TB Vaccines Industry Trends Table 10. TB Vaccines Industry Drivers Table 11. TB Vaccines Industry Opportunities and Challenges Table 12. TB Vaccines Industry Restraints Table 13. Global TB Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global TB Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global TB Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global TB Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global TB Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global TB Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global TB Vaccines Sales by Region (2021-2026) & (W Units) Table 20. Global TB Vaccines Sales by Region (2027-2032) & (W Units) Table 21. Global TB Vaccines Sales Market Share by Region (2021-2026) Table 22. Global TB Vaccines Sales Market Share by Region (2027-2032) Table 23. Global TB Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global TB Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global TB Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global TB Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global TB Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global TB Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global TB Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global TB Vaccines Manufacturers, Product Type & Application Table 31. Global TB Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global TB Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global TB Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global TB Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global TB Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global TB Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global TB Vaccines Sales by Type (2021-2026) & (W Units) Table 41. Global TB Vaccines Sales by Type (2027-2032) & (W Units) Table 42. Global TB Vaccines Sales Market Share by Type (2021-2026) Table 43. Global TB Vaccines Sales Market Share by Type (2027-2032) Table 44. Global TB Vaccines Price by Type (2021-2026) & (US$/Unit) Table 45. Global TB Vaccines Price by Type (2027-2032) & (US$/Unit) Table 46. Global TB Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global TB Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global TB Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global TB Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global TB Vaccines Sales by Application (2021-2026) & (W Units) Table 53. Global TB Vaccines Sales by Application (2027-2032) & (W Units) Table 54. Global TB Vaccines Sales Market Share by Application (2021-2026) Table 55. Global TB Vaccines Sales Market Share by Application (2027-2032) Table 56. Global TB Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global TB Vaccines Price by Application (2027-2032) & (US$/Unit) Table 58. China National Biotec Group Company Information Table 59. China National Biotec Group Business Overview Table 60. China National Biotec Group TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. China National Biotec Group TB Vaccines Product Portfolio Table 62. China National Biotec Group Recent Development Table 63. Sanofi Pasteur Company Information Table 64. Sanofi Pasteur Business Overview Table 65. Sanofi Pasteur TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur TB Vaccines Product Portfolio Table 67. Sanofi Pasteur Recent Development Table 68. Merck & Co.,Inc Company Information Table 69. Merck & Co.,Inc Business Overview Table 70. Merck & Co.,Inc TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck & Co.,Inc TB Vaccines Product Portfolio Table 72. Merck & Co.,Inc Recent Development Table 73. Statens Serum Institut Company Information Table 74. Statens Serum Institut Business Overview Table 75. Statens Serum Institut TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Statens Serum Institut TB Vaccines Product Portfolio Table 77. Statens Serum Institut Recent Development Table 78. Serum Institute Company Information Table 79. Serum Institute Business Overview Table 80. Serum Institute TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Serum Institute TB Vaccines Product Portfolio Table 82. Serum Institute Recent Development Table 83. Japan BCG Laboratory Company Information Table 84. Japan BCG Laboratory Business Overview Table 85. Japan BCG Laboratory TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Japan BCG Laboratory TB Vaccines Product Portfolio Table 87. Japan BCG Laboratory Recent Development Table 88. InterVax Ltd Company Information Table 89. InterVax Ltd Business Overview Table 90. InterVax Ltd TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. InterVax Ltd TB Vaccines Product Portfolio Table 92. InterVax Ltd Recent Development Table 93. India Pvt. Ltd Company Information Table 94. India Pvt. Ltd Business Overview Table 95. India Pvt. Ltd TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. India Pvt. Ltd TB Vaccines Product Portfolio Table 97. India Pvt. Ltd Recent Development Table 98. GreenSignal Company Information Table 99. GreenSignal Business Overview Table 100. GreenSignal TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GreenSignal TB Vaccines Product Portfolio Table 102. GreenSignal Recent Development Table 103. Bio Pharma Limited Company Information Table 104. Bio Pharma Limited Business Overview Table 105. Bio Pharma Limited TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bio Pharma Limited TB Vaccines Product Portfolio Table 107. Bio Pharma Limited Recent Development Table 108. North America TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 109. North America TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 110. North America TB Vaccines Sales by Type (2021-2026) & (W Units) Table 111. North America TB Vaccines Sales by Type (2027-2032) & (W Units) Table 112. North America TB Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America TB Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 115. North America TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 116. North America TB Vaccines Sales by Application (2021-2026) & (W Units) Table 117. North America TB Vaccines Sales by Application (2027-2032) & (W Units) Table 118. North America TB Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America TB Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America TB Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America TB Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America TB Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 124. North America TB Vaccines Sales by Country (2021-2026) & (W Units) Table 125. North America TB Vaccines Sales by Country (2027-2032) & (W Units) Table 126. North America TB Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America TB Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States TB Vaccines Revenue (2021-2032) & (US$ Million) Table 129. Canada TB Vaccines Revenue (2021-2032) & (US$ Million) Table 130. Europe TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe TB Vaccines Sales by Type (2021-2026) & (W Units) Table 133. Europe TB Vaccines Sales by Type (2027-2032) & (W Units) Table 134. Europe TB Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe TB Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe TB Vaccines Sales by Application (2021-2026) & (W Units) Table 139. Europe TB Vaccines Sales by Application (2027-2032) & (W Units) Table 140. Europe TB Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe TB Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe TB Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe TB Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe TB Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 146. Europe TB Vaccines Sales by Country (2021-2026) & (W Units) Table 147. Europe TB Vaccines Sales by Country (2027-2032) & (W Units) Table 148. Europe TB Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe TB Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany TB Vaccines Revenue (2021-2032) & (US$ Million) Table 151. France TB Vaccines Revenue (2021-2032) & (US$ Million) Table 152. U.K. TB Vaccines Revenue (2021-2032) & (US$ Million) Table 153. Italy TB Vaccines Revenue (2021-2032) & (US$ Million) Table 154. Netherlands TB Vaccines Revenue (2021-2032) & (US$ Million) Table 155. Nordic Countries TB Vaccines Revenue (2021-2032) & (US$ Million) Table 156. China TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 157. China TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 158. China TB Vaccines Sales by Type (2021-2026) & (W Units) Table 159. China TB Vaccines Sales by Type (2027-2032) & (W Units) Table 160. China TB Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China TB Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 163. China TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 164. China TB Vaccines Sales by Application (2021-2026) & (W Units) Table 165. China TB Vaccines Sales by Application (2027-2032) & (W Units) Table 166. China TB Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China TB Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia TB Vaccines Sales by Type (2021-2026) & (W Units) Table 171. Asia TB Vaccines Sales by Type (2027-2032) & (W Units) Table 172. Asia TB Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia TB Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia TB Vaccines Sales by Application (2021-2026) & (W Units) Table 177. Asia TB Vaccines Sales by Application (2027-2032) & (W Units) Table 178. Asia TB Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia TB Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia TB Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia TB Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia TB Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 184. Asia TB Vaccines Sales by Country (2021-2026) & (W Units) Table 185. Asia TB Vaccines Sales by Country (2027-2032) & (W Units) Table 186. Asia TB Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia TB Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan TB Vaccines Revenue (2021-2032) & (US$ Million) Table 189. South Korea TB Vaccines Revenue (2021-2032) & (US$ Million) Table 190. India TB Vaccines Revenue (2021-2032) & (US$ Million) Table 191. Australia TB Vaccines Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan TB Vaccines Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia TB Vaccines Revenue (2021-2032) & (US$ Million) Table 194. SAMEA TB Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA TB Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA TB Vaccines Sales by Type (2021-2026) & (W Units) Table 197. SAMEA TB Vaccines Sales by Type (2027-2032) & (W Units) Table 198. SAMEA TB Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA TB Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA TB Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA TB Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA TB Vaccines Sales by Application (2021-2026) & (W Units) Table 203. SAMEA TB Vaccines Sales by Application (2027-2032) & (W Units) Table 204. SAMEA TB Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA TB Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA TB Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA TB Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA TB Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 210. SAMEA TB Vaccines Sales by Country (2021-2026) & (W Units) Table 211. SAMEA TB Vaccines Sales by Country (2027-2032) & (W Units) Table 212. SAMEA TB Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA TB Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil TB Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Argentina TB Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Chile TB Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Colombia TB Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Peru TB Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia TB Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Israel TB Vaccines Revenue (2021-2032) & (US$ Million) Table 221. UAE TB Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Turkey TB Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Iran TB Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Egypt TB Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. TB Vaccines Distributors List Table 228. TB Vaccines Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. TB Vaccines Image Figure 2. Global TB Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TB Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immunotherapeutic Vaccines Image Figure 5. Booster Vaccines Image Figure 6. Others Image Figure 7. Global TB Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global TB Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. Private Clinics Image Figure 10. Research Institutes Image Figure 11. Hospitals Image Figure 12. Global TB Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global TB Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global TB Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global TB Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global TB Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global TB Vaccines Sales (2021-2032) & (W Units) Figure 18. Global TB Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global TB Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico TB Vaccines Sales YoY (2021-2032) & (W Units) Figure 21. Europe TB Vaccines Sales YoY (2021-2032) & (W Units) Figure 22. China TB Vaccines Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) TB Vaccines Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa TB Vaccines Sales YoY (2021-2032) & (W Units) Figure 25. Global TB Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global TB Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global TB Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global TB Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global TB Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global TB Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global TB Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global TB Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global TB Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global TB Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global TB Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global TB Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global TB Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global TB Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America TB Vaccines Revenue Share by Type (2021-2032) Figure 41. North America TB Vaccines Sales Share by Type (2021-2032) Figure 42. North America TB Vaccines Revenue Share by Application (2021-2032) Figure 43. North America TB Vaccines Sales Share by Application (2021-2032) Figure 44. North America TB Vaccines Revenue Share by Country (2021-2032) Figure 45. North America TB Vaccines Sales Share by Country (2021-2032) Figure 46. Europe TB Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe TB Vaccines Sales Share by Type (2021-2032) Figure 48. Europe TB Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe TB Vaccines Sales Share by Application (2021-2032) Figure 50. Europe TB Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe TB Vaccines Sales Share by Country (2021-2032) Figure 52. China TB Vaccines Revenue Share by Type (2021-2032) Figure 53. China TB Vaccines Sales Share by Type (2021-2032) Figure 54. China TB Vaccines Revenue Share by Application (2021-2032) Figure 55. China TB Vaccines Sales Share by Application (2021-2032) Figure 56. Asia TB Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia TB Vaccines Sales Share by Type (2021-2032) Figure 58. Asia TB Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia TB Vaccines Sales Share by Application (2021-2032) Figure 60. Asia TB Vaccines Revenue Share by Country (2021-2032) Figure 61. Asia TB Vaccines Sales Share by Country (2021-2032) Figure 62. SAMEA TB Vaccines Revenue Share by Type (2021-2032) Figure 63. SAMEA TB Vaccines Sales Share by Type (2021-2032) Figure 64. SAMEA TB Vaccines Revenue Share by Application (2021-2032) Figure 65. SAMEA TB Vaccines Sales Share by Application (2021-2032) Figure 66. SAMEA TB Vaccines Revenue Share by Country (2021-2032) Figure 67. SAMEA TB Vaccines Sales Share by Country (2021-2032) Figure 68. TB Vaccines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. TB Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapeutic Vaccines
  • Booster Vaccines
  • Others
Applications
  • Private Clinics
  • Research Institutes
  • Hospitals
Companies covered
  • China National Biotec Group
  • Sanofi Pasteur
  • Merck & Co.,Inc
  • Statens Serum Institut
  • Serum Institute
  • Japan BCG Laboratory
  • InterVax Ltd
  • India Pvt. Ltd
  • GreenSignal
  • Bio Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 TB Vaccines Market by Type
  3. 1.2.1 Global TB Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immunotherapeutic Vaccines
  5. 1.2.3 Booster Vaccines
  6. 1.2.4 Others
  7. 1.3 TB Vaccines Market by Application
  8. 1.3.1 Global TB Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Private Clinics
  10. 1.3.3 Research Institutes
  11. 1.3.4 Hospitals
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 TB Vaccines Market Dynamics
  1. 2.1 TB Vaccines Industry Trends
  2. 2.2 TB Vaccines Industry Drivers
  3. 2.3 TB Vaccines Industry Opportunities and Challenges
  4. 2.4 TB Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global TB Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global TB Vaccines Revenue by Region
  3. 3.2.1 Global TB Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global TB Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global TB Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global TB Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global TB Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global TB Vaccines Sales by Region
  9. 3.4.1 Global TB Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global TB Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global TB Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global TB Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global TB Vaccines Revenue by Manufacturers
  2. 4.1.1 Global TB Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global TB Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global TB Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global TB Vaccines Sales by Manufacturers
  6. 4.2.1 Global TB Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global TB Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global TB Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global TB Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global TB Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global TB Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global TB Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global TB Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global TB Vaccines Market CR5 and HHI
  16. 4.8.2 2025 TB Vaccines Tier 1, Tier 2, and Tier 3
5 TB Vaccines Market by Type
  1. 5.1 Global TB Vaccines Revenue by Type
  2. 5.1.1 Global TB Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global TB Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global TB Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global TB Vaccines Sales by Type
  6. 5.2.1 Global TB Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global TB Vaccines Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global TB Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global TB Vaccines Price by Type
6 TB Vaccines Market by Application
  1. 6.1 Global TB Vaccines Revenue by Application
  2. 6.1.1 Global TB Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global TB Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global TB Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global TB Vaccines Sales by Application
  6. 6.2.1 Global TB Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global TB Vaccines Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global TB Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global TB Vaccines Price by Application
7 Company Profiles
  1. 7.1 China National Biotec Group
  2. 7.1.1 China National Biotec Group Company Information
  3. 7.1.2 China National Biotec Group Business Overview
  4. 7.1.3 China National Biotec Group TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China National Biotec Group TB Vaccines Product Portfolio
  6. 7.1.5 China National Biotec Group Recent Developments
  7. 7.2 Sanofi Pasteur
  8. 7.2.1 Sanofi Pasteur Company Information
  9. 7.2.2 Sanofi Pasteur Business Overview
  10. 7.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pasteur TB Vaccines Product Portfolio
  12. 7.2.5 Sanofi Pasteur Recent Developments
  13. 7.3 Merck & Co.,Inc
  14. 7.3.1 Merck & Co.,Inc Company Information
  15. 7.3.2 Merck & Co.,Inc Business Overview
  16. 7.3.3 Merck & Co.,Inc TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck & Co.,Inc TB Vaccines Product Portfolio
  18. 7.3.5 Merck & Co.,Inc Recent Developments
  19. 7.4 Statens Serum Institut
  20. 7.4.1 Statens Serum Institut Company Information
  21. 7.4.2 Statens Serum Institut Business Overview
  22. 7.4.3 Statens Serum Institut TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Statens Serum Institut TB Vaccines Product Portfolio
  24. 7.4.5 Statens Serum Institut Recent Developments
  25. 7.5 Serum Institute
  26. 7.5.1 Serum Institute Company Information
  27. 7.5.2 Serum Institute Business Overview
  28. 7.5.3 Serum Institute TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute TB Vaccines Product Portfolio
  30. 7.5.5 Serum Institute Recent Developments
  31. 7.6 Japan BCG Laboratory
  32. 7.6.1 Japan BCG Laboratory Company Information
  33. 7.6.2 Japan BCG Laboratory Business Overview
  34. 7.6.3 Japan BCG Laboratory TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Japan BCG Laboratory TB Vaccines Product Portfolio
  36. 7.6.5 Japan BCG Laboratory Recent Developments
  37. 7.7 InterVax Ltd
  38. 7.7.1 InterVax Ltd Company Information
  39. 7.7.2 InterVax Ltd Business Overview
  40. 7.7.3 InterVax Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 InterVax Ltd TB Vaccines Product Portfolio
  42. 7.7.5 InterVax Ltd Recent Developments
  43. 7.8 India Pvt. Ltd
  44. 7.8.1 India Pvt. Ltd Company Information
  45. 7.8.2 India Pvt. Ltd Business Overview
  46. 7.8.3 India Pvt. Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 India Pvt. Ltd TB Vaccines Product Portfolio
  48. 7.8.5 India Pvt. Ltd Recent Developments
  49. 7.9 GreenSignal
  50. 7.9.1 GreenSignal Company Information
  51. 7.9.2 GreenSignal Business Overview
  52. 7.9.3 GreenSignal TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GreenSignal TB Vaccines Product Portfolio
  54. 7.9.5 GreenSignal Recent Developments
  55. 7.10 Bio Pharma Limited
  56. 7.10.1 Bio Pharma Limited Company Information
  57. 7.10.2 Bio Pharma Limited Business Overview
  58. 7.10.3 Bio Pharma Limited TB Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bio Pharma Limited TB Vaccines Product Portfolio
  60. 7.10.5 Bio Pharma Limited Recent Developments
8 North America
  1. 8.1 North America TB Vaccines Market Size by Type
  2. 8.1.1 North America TB Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America TB Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America TB Vaccines Price by Type (2021-2032)
  5. 8.2 North America TB Vaccines Market Size by Application
  6. 8.2.1 North America TB Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America TB Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America TB Vaccines Price by Application (2021-2032)
  9. 8.3 North America TB Vaccines Market Size by Country
  10. 8.3.1 North America TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America TB Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America TB Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe TB Vaccines Market Size by Type
  2. 9.1.1 Europe TB Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe TB Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe TB Vaccines Price by Type (2021-2032)
  5. 9.2 Europe TB Vaccines Market Size by Application
  6. 9.2.1 Europe TB Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe TB Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe TB Vaccines Price by Application (2021-2032)
  9. 9.3 Europe TB Vaccines Market Size by Country
  10. 9.3.1 Europe TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe TB Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe TB Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China TB Vaccines Market Size by Type
  2. 10.1.1 China TB Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China TB Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China TB Vaccines Price by Type (2021-2032)
  5. 10.2 China TB Vaccines Market Size by Application
  6. 10.2.1 China TB Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China TB Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China TB Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia TB Vaccines Market Size by Type
  2. 11.1.1 Asia TB Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia TB Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia TB Vaccines Price by Type (2021-2032)
  5. 11.2 Asia TB Vaccines Market Size by Application
  6. 11.2.1 Asia TB Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia TB Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia TB Vaccines Price by Application (2021-2032)
  9. 11.3 Asia TB Vaccines Market Size by Country
  10. 11.3.1 Asia TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia TB Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia TB Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA TB Vaccines Market Size by Type
  2. 12.1.1 SAMEA TB Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA TB Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA TB Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA TB Vaccines Market Size by Application
  6. 12.2.1 SAMEA TB Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA TB Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA TB Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA TB Vaccines Market Size by Country
  10. 12.3.1 SAMEA TB Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA TB Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA TB Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 TB Vaccines Value Chain Analysis
  2. 13.1.1 TB Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 TB Vaccines Production Mode & Process
  6. 13.2 TB Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 TB Vaccines Distributors
  9. 13.2.3 TB Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst